(Q53243983)

English

A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.

scientific article published on 4 January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17203353

A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17203353

object named as

Serenoa repens

1 reference

based on heuristic

inferred from title

author name string

Fatih Hizli

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17203353

M Cemil Uygur

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17203353

publication date

4 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17203353

International Urology and Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17203353

39

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17203353

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17203353

879-886

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17203353

A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1007%2FS11255-006-9106-5

21 January 2018

Why do patients turn to complementary medicine? An empirical study

1 reference

https://api.crossref.org/works/10.1007%2FS11255-006-9106-5

21 January 2018

Watchful waiting or drug therapy for benign prostatic hyperplasia?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamsulosin: 3-year long-term efficacy and safety in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction: analysis of a European, multinational, multicenter, open-label study. European Tamsulosin Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phytotherapy in the treatment of benign prostatic hyperplasia: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The attitudes, behaviors and beliefs of patients of conventional vs. complementary (alternative) medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Why patients use alternative medicine: results of a national study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urodynamic effects of doxazosin in men with lower urinary tract symptoms and benign prostatic obstruction. Results from three double-blind placebo-controlled studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protracted cholestatic hepatitis after the use of prostata

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alfuzosin for treatment of benign prostatic hypertrophy. The BPH-ALF Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phytotherapy for the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of benign prostatic hyperplasia with phytosterols

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The lipidosterolic extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a comparison of two dosage regimens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saw palmetto for benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical management of benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel aromatase and 5 alpha-reductase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical therapy for benign prostatic hyperplasia: a review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the lipidosterolic extract of Serenoa repens (Permixon) on human prostatic cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience in treating benign prostatic hypertrophy with Sabal serrulata for one year

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sabal serrulata extract (Strogen forte) in the treatment of symptomatic benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benign prostatic hyperplasia. Medical and minimally invasive treatment options

1 reference

https://pubmed.ncbi.nlm.nih.gov/17203353

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11255-006-9106-5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17203353

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17203353

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53243983&oldid=1610912951"